Leanlife Health Stock Price To Earnings To Growth
| LNLHF Stock | USD 0.01 0.00 0.00% |
LeanLife Health fundamentals help investors to digest information that contributes to LeanLife Health's financial success or failures. It also enables traders to predict the movement of LeanLife Pink Sheet. The fundamental analysis module provides a way to measure LeanLife Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to LeanLife Health pink sheet.
LeanLife |
LeanLife Health Company Price To Earnings To Growth Analysis
LeanLife Health's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Based on the latest financial disclosure, LeanLife Health has a Price To Earnings To Growth of 0.0 times. This is 100.0% lower than that of the Consumer Defensive sector and 100.0% lower than that of the Packaged Foods industry. The price to earnings to growth for all United States stocks is 100.0% higher than that of the company.
Did you try this?
Run Idea Breakdown Now
Idea BreakdownAnalyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
| All Next | Launch Module |
LeanLife Fundamentals
| Return On Equity | -8.07 | |||
| Return On Asset | -1.5 | |||
| Current Valuation | 3.86 M | |||
| Shares Outstanding | 207.11 M | |||
| Shares Owned By Insiders | 1.51 % | |||
| Price To Book | 46.62 X | |||
| EBITDA | (3.66 M) | |||
| Net Income | (3.67 M) | |||
| Cash And Equivalents | 4.07 K | |||
| Total Debt | 747.4 K | |||
| Debt To Equity | 0.38 % | |||
| Current Ratio | 0.52 X | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (1.21 M) | |||
| Earnings Per Share | (0.02) X | |||
| Beta | 0.48 | |||
| Market Capitalization | 3.73 M | |||
| Total Asset | 1.29 M | |||
| Z Score | -4.2 | |||
| Net Asset | 1.29 M |
About LeanLife Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze LeanLife Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LeanLife Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LeanLife Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in LeanLife Pink Sheet
LeanLife Health financial ratios help investors to determine whether LeanLife Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in LeanLife with respect to the benefits of owning LeanLife Health security.